Page 3 - Piramal

Piramal Pharma partners with Norway firm to develop leukemia treatment drug

Piramal Pharma Solutions will partner, Bemcentinib, an AXL protein inhibitor for oncology which was recently designated as a Fast Track drug by the US Food and Drug Administration

Piramal Capital borrows Rs 1100 crore for 4 months from Barclays: Report

The rate of interest is 7.5 per cent on the four-month loan deal signed last week between Piramal Capital & Housing Finance Ltd. and the British bank

Nifty outlook and top trading ideas by Jay Anand Thakkar of Anand Rathi

Nifty has again started to form higher tops and bottoms and has finally provided a breakout from the crucial swing resistance of 12,040 levels

Piramal Ent seeks shareholders' nod to raise Rs 1,750 crore via CCDs

As part of the agreement, Piramal Enterprises will issue and allot 1,15,894 CCDs at a face value of Rs 1.51 lakh.

Canadian pension fund's stake in Piramal Enterprises may rise up to 9%

The fundraising announcement was a result of a liquidity challenge faced by non-banking financial companies

Piramal knocks Sebi's door to counter rumours about financial services biz

Rumour mongering on blogs and social media platforms is being done to create panic among various stakeholders, PEL said in a filing with the exchanges

Top headlines: TCS misses estimates in Q2; Piramal files complaint

TCS missed analysts' estimates for September-quarter profit, as India's No. 1 IT services exporter faced sluggish demand.

From arbitration clause to IT Act, here are the key court orders

An employer cannot dispute his liability to pay wages because of the sickness of the unit or pendency of a BIFR rehabilitation scheme

No plans to re-enter domestic formulations in current fiscal: Piramal V-C

Last year, Ajay Piramal, chairman of Piramal Enterprises, had indicated that the firm was exploring a possible re-entry into the domestic formulations market

Trying to bring Shriram Group units under one unit, says Ajay Piramal

Piramal Enterprises has a 20% stake in unlisted Shriram Capital and 10% each in Shriram Transport and Shriram City Union

Piramal Enterprises plans to raise up to Rs 26.50 bn through NCDs

The NCDs are proposed to be listed in the wholesale debt market segment of the NSE, the company said

Piramal to back Chennai-based Appaswamy group, sanctions Rs 2 bn

Funding will help recipient firm acquire 3.34 acres in Chennai, develop a premium residential project with potential revenue in excess of Rs 10 bn

Piramal gives Rs 1,100 crore to Embassy for southern projects

Piramal Enterprises Limited through its subsidiary Piramal Finance Limited (PFL) has financed the Embassy Group for an amount of Rs 1100 crore. The money will support company's project in South India.This is a Loan investment, debt investment at a corporate level, said the company. This funding has been done sequentially across both residential and commercial projects in Bangalore, Chennai and Hyderabad over a span of the last six months. PFL first funded Rs 360 crore towards Embassy Residences in Chennai - a premium residential project spread over 25 acres with ~0.3 million sq. ft. of built up area and followed up with an investment in Phoenix-Embassy which is a joint venture between Embassy and Phoenix Group of Hyderabad.The JV is developing ~1.5 million sq. ft. of grade-A commercial space in the financial district of Hyderabad with a potential to develop a further 4 million sq ft. Subsequently, PFL has provided INR650cr of growth capital to the Embassy Group in Bangalore.The ...

Piramal to acquire 5 brands from Janssen Pharma

Janssen Pharmaceutica, can earn up to an additional $20 million if the product portfolio achieves certain agreed financial milestones

Piramal to buy four Pfizer brands for Rs 110 cr

Would also purchase trademark rights for Ferradol and Waterbury's Compound in Bangladesh and Sri Lanka

Piramal directors give nod to raise to raise Rs 100 crore

Shares of the company closed 2.19% up at Rs 957.55 apiece on BSE